You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
After more than 10 years of development in flow diversion therapies, the 4th generation Pipeline™ VANTAGE Embolization Device with Shield Technology™ continues the legacy by providing meaningful innovation with delivered enhancements in biomaterial science & technology.Download Brochure
Medtronic Neurovascular has been leading the way in flow diversion for over 10 years.
Our lasting commitment to evidence-based medicine and clinically proven safety and efficacy is demonstrated in our legacy of robust clinical trials. Through this commitment, we are driven towards advancing flow diversion therapy of intracranial aneurysms for patients worldwide.
4 Generations of Pipeline™ :
• Pipeline™ Embolization Device*
• Pipeline™ Flex Embolization Device
• Pipeline™ Flex Embolization Device with Shield TechnologyTM
• Pipeline™ Vantage Embolization Device with Shield TechnologyTM
Promote Tissue Endothelialization
Via Balance of 4 key elements
Enhanced Scaffolding Effect To Optimize Vessel Remodeling
• Cobalt chromium wires for implant shape memory
• Platinum wires for implant visibility
Integrated wire design:
• Drawn filled tube with a cobalt chromium (CoCr) shell and platinum core + 16 solid CoCr wires
Higher Wire Count
The large diameter 64 wire Pipeline™ Vantage braids increase relative pore density, reduce wall thickness & maintain metal surface coverage in the same range as the predicate device.
48 wires for all braid diameters
48 wires for 2.50-3.50 mm braids
64 wires for 4.00-6.00 mm braids
Access Distal Anatomy
.021” COMPATIBLE FOR SMALL DIAMETERS
.027”COMPATIBLE FOR LARGE DIAMETERS
Medtronic Study Marketing Claims Validation Report D00119680 Rev. A
Pre-Clinical Publication: Matsuda Y, Chung J, Lopes DKAnalysis of neointima development in flow diverters using optical coherence tomography imaging Journal of NeuroInterventional Surgery 2018;10:162-167.
*The Pipeline™ Embolization Device (Classic) is no longer licensed for sale in Canada.